Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been published in the European Patent Bulletin.
Publication of the patent application in the European Patent Bulletin follows entry into the European phase under the Patent Cooperation Treaty and represents a key milestone in Genflow’s expanding intellectual property portfolio.
The market narrative is increasingly shifting towards select pockets of growth within banking, consumption, and healthcare, says Shibani Sircar Kurian,...
Oil prices pushed higher for a second day on Wednesday, buoyed by sanctions-related supply risks, hopes of a U.S.-China trade...
Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking...
Young jobseekers, challenged by a rapidly changing labor market, are having a tough time. The U.S. unemployment rate for 22-...
Hello and welcome to Eye on AI. In this edition…A breakdown of the AI news from Salesforce’s Dreamforce…OpenAI debuts its...
OpenAI unveiled a web browser on Tuesday in a bid to make its ChatGPT AI product the starting point for...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
